跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HP-200
首页
药物
HP-200
HP-200
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Aqueous solution containing coenzyme Q10 nano granule and preparation method thereof
CN 101485626 B
申请人: SHENZHOU TIANCHEN SCIENCE & TECHNOLOGY IND CO LTD
优先权: 2009
CN
Method for extracting alpha-glucosidase inhibitor of small intestines from China soapberry
CN 102166274 B
申请人: UNIV SICHUAN
优先权: 2011
CN
Method for extracting alpha-glucosaccharase inhibitor from Fructus Terminaliae Immaturus
CN 102266360 B
申请人: UNIV SICHUAN
优先权: 2011
CN
Strychnine-hydroxypropyl-beta-cyclodextrin liposome, preparation method and applications thereof
CN 103222956 A
申请人: UNIV SOUTH CHINA TECH
优先权: 2013
CN
Traditional Chinese medicine composition and preparation method and use thereof
CN 105797113 A
申请人: SOUTHWEST MEDICAL UNIV AFFILIATED HOSPITAL OF TRADITIONAL CHINESE MEDICINE
优先权: 2016
CN
Purification method for recombinant human interleukin-12
CN 105924514 A
申请人: QINGDAO KANGLITAI PHARMACEUTICAL COMPANY LTD
优先权: 2016
CN
Resveratrol solid dispersion and method for improving solubility of resveratrol in red wine
CN 107029248 A
申请人: HUBEI SANXIN BIOTECHNOLOGY CO LTD
优先权: 2017
CN
一种抗Hp感染促进胃部菌群平衡的组合物及其应用
CN 109497557 B
申请人: 赵勤农
优先权: 2019
CN
Self-nanoemulsion drug release system
CN 119656113 A
申请人: JIANGSU KANION PHARMACEUTICAL CO LTD
优先权: 2023
CN
药物
反馈